I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Leighl, N.
272
results:
Search for persons
X
Format
Online (272)
Mediatypes
Articles (Online) (151)
Bookchapter (Online) (1)
OpenAccess-fulltext (120)
Sorted by: Relevance
Sorted by: Year
?
1
71P A phase I study of binimetinib, a MEK inhibitor, in com..:
Theriau, C.
;
Feng, J.
;
Eng, L.
...
ESMO Open. 9 (2024) - p. 102650 , 2024
Link:
https://doi.org/10.1016/..
?
2
31P Myelosuppression risk from epidermal growth factor rece..:
Girard, N.
;
Liu, S.V.
;
Nassib William Junior, W.
...
ESMO Open. 9 (2024) - p. 102610 , 2024
Link:
https://doi.org/10.1016/..
?
3
Single organ metastatic sites in non-small cell lung cancer..:
Li, Y.
;
Wong, M.
;
Zhan, L.
...
Lung Cancer. 192 (2024) - p. 107823 , 2024
Link:
https://doi.org/10.1016/..
?
4
6MO Subcutaneous amivantamab administered every 4 weeks (Q4..:
Leighl, N.
;
Minchom, A.R.
;
Lee, K.H.H.
...
ESMO Open. 9 (2024) - p. 102585 , 2024
Link:
https://doi.org/10.1016/..
?
5
48P Real-world clinical utility of next-generation sequenci..:
García Pardo de Santayana, M.
;
García de Herreros, M.
;
Laguna, J.C.
...
ESMO Open. 9 (2024) - p. 102627 , 2024
Link:
https://doi.org/10.1016/..
?
6
EP12.01-42 Long-term Survivors with EGFR Positive Non-Small..:
Halperin, H.
;
Gibson, A.J.W.
;
Sung, M.
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S657 , 2023
Link:
https://doi.org/10.1016/..
?
7
Negative Predictive Value of Pre-diagnostic Plasma ctDNA Te..:
García-Pardo, M.
;
Czarnecka-Kujawa, K.
;
Le, L.
...
The Journal of Liquid Biopsy. 1 (2023) - p. 100028 , 2023
Link:
https://doi.org/10.1016/..
?
8
27P Amivantamab versus alternative real-world anti-cancer t..:
Girard, N.
;
Wolf, J.
;
Kim, T.M.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S56 , 2023
Link:
https://doi.org/10.1016/..
?
9
30 Long-term efficacy, safety, and predictors of response t..:
Lopez, P. Garrido
;
Girard, N.
;
Cho, B.C.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S36-S37 , 2023
Link:
https://doi.org/10.1016/..
?
10
19P Mortality among EGFR-mutated advanced NSCLC patients af..:
Girard, N.
;
Leighl, N.
;
Ohe, Y.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S51-S52 , 2023
Link:
https://doi.org/10.1016/..
?
11
Longitudinal Plasma ctDNA Testing in Resected Early-Stage N..:
Feng, J.
;
Waddell, T.
;
Yasufuku, K.
...
The Journal of Liquid Biopsy. 1 (2023) - p. 100012 , 2023
Link:
https://doi.org/10.1016/..
?
12
65O Phase III LEAP-008 study of lenvatinib plus pembrolizum..:
Leighl, N.
;
Paz-Ares, L.
;
Abreu, D. Rodriguez
...
Immuno-Oncology and Technology. 20 (2023) - p. 100537 , 2023
Link:
https://doi.org/10.1016/..
?
13
170P Preliminary results from LUMINANCE: A phase IIIb, sing..:
Reinmuth, N.
;
de Marinis, F.
;
Leighl, N.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S134 , 2023
Link:
https://doi.org/10.1016/..
?
14
Survival Outcomes of Extensive Stage Small Cell Lung Cancer..:
Sugumar, V.
;
Sr, R. R. Salunkhe
;
Ye, X.Y.
...
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e60 , 2023
Link:
https://doi.org/10.1016/..
?
15
OA21.04 Amivantamab in Patients with Advanced NSCLC and MET..:
Leighl, N.
;
Cho, B.C.
;
Hiret, S.
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S93-S94 , 2023
Link:
https://doi.org/10.1016/..
1-15